Nonprofit drug developer in uphill battle against Trump administration contraception rule change

Medicines360 launched its low-priced contraceptive last year in Madagascar. It is awaiting regulatory approval in Kenya, and it has asked the Nigerian government for a green light. One country, however, is causing the leaders of the San Francisco-based nonprofit significant angst: the United States. Proposed rule changes by the Trump administration would limit the availability of and access to Medicines360’s long-acting, reversible intrauterine device, or IUD. While a dec ision could have serious…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news